drugset / Trial / NCT00005628
Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma
Treatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have recurrent soft tissue sarcoma.
Timeline
- Start
- 1999-11
- Primary completion
- 2001-08
- Completion
- 2001-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | vitespen | Vaccine | — | Other |